| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1126/SCITRANSLMED.3002302 |
| P698 | PubMed publication ID | 21795590 |
| P50 | author | Stanley Plotkin | Q7599873 |
| P2093 | author name string | Steven Black | |
| S Sohail Ahmed | |||
| Robert L Coffman | |||
| P2860 | cites work | Vaccination and autoimmune disease: what is the evidence? | Q35590061 |
| The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor | Q36370212 | ||
| Immunopathogenesis and immunotherapy of multiple sclerosis | Q36577275 | ||
| Genetics of SLE in mice | Q36593309 | ||
| Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes | Q37073520 | ||
| CpG-containing immunostimulatory DNA sequences elicit TNF-alpha-dependent toxicity in rodents but not in humans | Q37328524 | ||
| CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract | Q37369552 | ||
| Mechanism of action of clinically approved adjuvants | Q37402088 | ||
| Review of recent genome-wide association scans in lupus | Q37506571 | ||
| Immunostimulatory oligonucleotides attenuate airways remodeling in allergic monkeys | Q37590892 | ||
| Genetic dimorphism in influenza viruses: Characterization of stably associated hemagglutinin mutants differing in antigenicity and biological properties | Q37597467 | ||
| Nonclinical safety assessment of vaccines and adjuvants | Q37680762 | ||
| Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides | Q38289912 | ||
| Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA. | Q38332236 | ||
| A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children. | Q38346472 | ||
| Toll-like receptor ligands directly promote activated CD4+ T cell survival | Q39442360 | ||
| The immunogenetics of smallpox vaccination. | Q40447133 | ||
| Clinical responses to undiluted and diluted smallpox vaccine | Q40585736 | ||
| Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences | Q41675520 | ||
| Genetic composition of a high-yielding influenza A virus recombinant: a vaccine strain against "Swine" influenza | Q41846229 | ||
| Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). | Q42040328 | ||
| CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo | Q42918230 | ||
| Voluntary exploratory data submissions to the US FDA and the EMA: experience and impact | Q43049704 | ||
| Dose-related effects of smallpox vaccine | Q43970734 | ||
| Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions | Q45399390 | ||
| Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. | Q47315232 | ||
| Lancet retracts Wakefield's MMR paper | Q50305184 | ||
| Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses. | Q54611174 | ||
| Immune mechanisms of protection: can adjuvants rise to the challenge? | Q21245319 | ||
| Molecular mechanisms of autoimmunity triggered by microbial infection | Q24812576 | ||
| Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses | Q27487514 | ||
| Collaboration, genetic associations, and lupus erythematosus | Q28265215 | ||
| Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans | Q29616204 | ||
| Recognition of microorganisms and activation of the immune response | Q29617903 | ||
| Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412 | Q29622893 | ||
| Molecular and cellular signatures of human vaccine adjuvants. | Q30370898 | ||
| Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys. | Q30380132 | ||
| MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. | Q30380647 | ||
| Seasonal and Pandemic A (H1N1) 2009 influenza vaccination coverage and attitudes among health-care workers in a Spanish University Hospital. | Q30389171 | ||
| Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey | Q30398499 | ||
| Likely uptake of swine and seasonal flu vaccines among healthcare workers. A cross-sectional analysis of UK telephone survey data. | Q30399085 | ||
| Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10 - results from thirteen consecutive cross-sectional surveys | Q30401490 | ||
| Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient | Q33330476 | ||
| Association of interacting genes in the toll-like receptor signaling pathway and the antibody response to pertussis vaccination | Q33382988 | ||
| Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994). | Q33496135 | ||
| Epidemiology and estimated population burden of selected autoimmune diseases in the United States | Q33500191 | ||
| Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice | Q33632219 | ||
| Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis | Q33784386 | ||
| Plasmacytoid dendritic cells: the key to CpG. | Q34164404 | ||
| The epidemiology of autoimmune diseases | Q34212462 | ||
| Epidemiology of autoimmune reactions induced by vaccination | Q34239672 | ||
| Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity | Q34491896 | ||
| Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59. | Q34582628 | ||
| Recent advances in vaccine adjuvants | Q34756188 | ||
| P433 | issue | 93 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 93rv2 | |
| P577 | publication date | 2011-07-01 | |
| P1433 | published in | Science Translational Medicine | Q1573955 |
| P1476 | title | Assessing the safety of adjuvanted vaccines | |
| P478 | volume | 3 |
| Q39160011 | Adjuvants: tailoring humoral immune responses |
| Q30376254 | Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. |
| Q43196711 | B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses |
| Q26824573 | Beyond empiricism: informing vaccine development through innate immunity research |
| Q30222083 | Clinical vaccine development for H5N1 influenza |
| Q35849215 | Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates |
| Q30877907 | Enhancement of MHC-I antigen presentation via architectural control of pH-responsive, endosomolytic polymer nanoparticles. |
| Q30359243 | GLA-AF, an emulsion-free vaccine adjuvant for pandemic influenza. |
| Q27016633 | Immune response to vaccine adjuvants during the first year of life |
| Q33924419 | In Vivo Synthesis of Cyclic-di-GMP Using a Recombinant Adenovirus Preferentially Improves Adaptive Immune Responses against Extracellular Antigens. |
| Q40587195 | Influenza immunization during pregnancy: Benefits for mother and infant |
| Q89777595 | Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs |
| Q30386292 | Mechanistic insights into influenza vaccine-associated narcolepsy. |
| Q34532064 | Molecular and cellular response profiles induced by the TLR4 agonist-based adjuvant Glucopyranosyl Lipid A |
| Q40077881 | Potent adjuvantic activity of a CCR1-agonistic bis-quinoline |
| Q52348342 | Preparation of Modified Konjac Glucomannan Nanoparticles and their Application as Vaccine Adjuvants to Promote Ovalbumin-Induced Immune Response in Mice. |
| Q27025822 | Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants |
| Q92039567 | Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination |
| Q30205195 | Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses |
| Q35498054 | Using Poly I:C as an adjuvant does not induce or exacerbate models of systemic lupus erythematosus |
| Q26783879 | Vaccine Adjuvants: from 1920 to 2015 and Beyond |
| Q37119456 | Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century |
| Q33703757 | pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides |
Search more.